A Review on Repositioning Antidiabetic Therapies for Alzheimer’s and Parkinson’s Disease: Targeting the Metabolic–Neurodegenerative Interface

Copyright & License

Copyright © 2026 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

BibTeX

@article{191892,
        author = {Uriti Sri Venkatesh and Avijeet Karmakar and Sourabh Bagoria and Ravi Kumar and Salauddin and Aranyak Mahapatra and Ayman S Peerzade},
        title = {A Review on Repositioning Antidiabetic Therapies for Alzheimer’s and Parkinson’s Disease: Targeting the Metabolic–Neurodegenerative Interface},
        journal = {International Journal of Innovative Research in Technology},
        year = {2026},
        volume = {12},
        number = {8},
        pages = {7990-8005},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=191892},
        abstract = {},
        keywords = {},
        month = {January},
        }

Cite This Article

Venkatesh, U. S., & Karmakar, A., & Bagoria, S., & Kumar, R., & Salauddin, , & Mahapatra, A., & Peerzade, A. S. (2026). A Review on Repositioning Antidiabetic Therapies for Alzheimer’s and Parkinson’s Disease: Targeting the Metabolic–Neurodegenerative Interface. International Journal of Innovative Research in Technology (IJIRT). https://doi.org/doi.org/10.64643/IJIRTV12I8-191892-459

Related Articles